Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-16-104312

Options or other derivatives

  • Chief Scientific Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Weichert Jamey P Chief Scientific Officer 2016-05-12 Grant or award · Stock option (right to buy) +40,000 $0.01 $400 42,895 D
Loading xslF345X03/v440761_4.xml…